Addressing the Disparity: Treating Childhood Cancer in Low and Middle-Income Countries

By Staff Writer

December 13, 2023

The Stark Reality of Childhood Cancer Treatment in LMICs

Every year, the World Health Organisation (WHO) reports an estimated 400,000 children and adolescents aged 0-19 develop cancer. The most common types are leukaemias, brain cancers, lymphomas, and solid tumours, such as neuroblastoma and Wilms tumours. High-income countries (HICs), which house only 20% of the world’s children with cancer, boast cure rates exceeding 80%. In stark contrast, Childhood Cancer Treatment in LMICs only manage a 30% cure rate.

The Challenges of Healthcare in LMICs

The economies of most LMICs are at an early stage of development, marked by poverty, health-care worker shortages, weak health systems, low education levels, and limited access to modern technology and healthcare facilities. Paediatric oncology, the specialised field dealing with cancers in children and adolescents, demands a high level of expertise and resources. Unfortunately, these are often lacking in LMICs, exacerbating the problem of childhood cancer.

The Essential Components of Effective Childhood Cancer Treatment

Effective treatment of childhood cancer requires a robust system with specialised diagnostic and therapeutic capabilities. Key elements include trained paediatric oncologists, surgeons, pathologists, radiation oncologists, radiologists, pharmacists, and nurses. Reliable supplies of chemotherapeutic agents, supportive care medications, and blood products are crucial. Diagnostic imaging capabilities and basic laboratory services are also vital. However, even with these in place, treatment abandonment remains a significant cause of treatment failure in many LMICs.

The Importance of National Cancer Plans (NCPs) in LMICs

Most LMICs lack policies to ensure good paediatric oncology care and do not have a National Cancer Plan (NCP). An NCP is a public health programme aimed at increasing diagnosis, reducing the number of deaths, and improving the quality of life of cancer patients. It promotes the development of management guidelines, emphasises early referral pathways, lowers morbidity and mortality, and improves the quality of life of cancer patients, regardless of their birthplace.

Education and Training Initiatives in LMICs

Education and public awareness are crucial components in the fight against childhood cancer. For instance, the CHOC Childhood Cancer Foundation has been collaborating with the Department of Health and Traditional Healers Organisations since 2011 to educate health professionals, healthcare workers, and communities about childhood cancer. This initiative aims to bust myths, reduce stigma, and improve early diagnosis and treatment. Furthermore, CHOC has recently trained its employees and volunteers on how to become effective facilitators and advocates in communities. To date, they have trained close to 30,000 trainees in seven of the nine provinces of South Africa, demonstrating a significant stride towards improving childhood cancer outcomes in LMICs.

Reference url

Recent Posts

lenacapavir HIV prevention
      

Lenacapavir HIV Prevention: Approval and Access Strategy Updates

🌍 *Could a twice-yearly shot revolutionize HIV prevention?*
Gilead Sciences has submitted key applications to the EMA for lenacapavir, a groundbreaking HIV-1 capsid inhibitor designed for use as pre-exposure prophylaxis (PrEP). With promising trial results indicating a significant reduction in HIV infections, this innovation could enhance adherence to prevention strategies globally. Discover more about this game-changing development!

#SyenzaNews #globalhealth #healthcareInnovation

Africa health partnership
      

Strengthening Africa Health Partnership

🌍 Can collaboration redefine Africa’s health landscape?

A newly signed Memorandum of Understanding between Africa CDC and Global Health EDCTP3 promises to enhance health research, clinical trials, and pandemic preparedness on the continent. With a focus on training, local manufacturing, and equitable partnerships, this initiative aims to address pressing global health challenges while improving health outcomes across Africa.

Look into the details of this transformative partnership and its implications for the future of healthcare in the region!

#SyenzaNews #globalhealth #HealthcareInnovation

breast cancer Africa
    

Urgent Call for Enhanced Breast Cancer Africa Control Measures

🚨 Are we doing enough to tackle the imminent breast cancer crisis in Africa?

A recent WHO report reveals alarming trends, predicting that 135,000 women could succumb to breast cancer by 2040 unless urgent actions are taken. The report highlights critical gaps in healthcare infrastructure and capacity, emphasizing the need for investment in screening programs and professional training to improve outcomes across the continent.

Review the full article to explore the necessary steps towards reinforcing breast cancer control measures in Africa.

#SyenzaNews #globalhealth #oncology #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.